A new study covered by Bloomberg finds people on GLP-1 drugs had fewer hospital visits tied to schizophrenia, adding to research on psychiatric effects.
Recap by typeshit. Full story at Bloomberg.com.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
Hollis talks through the investigational obesity drug and asks what the research could mean beyond the number on the scale.
The International Association of Trichologists says the review saw promise in short peptides for hair follicles, but most remain unproven.
Loading…